Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Receivables - Net: 2020-2024

Historic Receivables - Net for Oncology Institute (TOI) over the last 5 years, with FY2024 value amounting to $48.3 million.

  • Oncology Institute's Receivables - Net rose 942.53% to $59.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.6 million, marking a year-over-year increase of 942.53%. This contributed to the annual value of $48.3 million for FY2024, which is 1410.53% up from last year.
  • Oncology Institute's Receivables - Net amounted to $48.3 million in FY2024, which was up 1410.53% from $42.4 million recorded in FY2023.
  • In the past 5 years, Oncology Institute's Receivables - Net ranged from a high of $48.3 million in FY2024 and a low of $17.1 million during FY2020
  • For the 5-year period, Oncology Institute's Receivables - Net averaged around $33.5 million, with its median value being $39.8 million (2022).
  • Per our database at Business Quant, Oncology Institute's Receivables - Net surged by 9901.03% in 2022 and then surged by 638.94% in 2023.
  • Annual analysis of 5 years shows Oncology Institute's Receivables - Net stood at $17.1 million in 2020, then rose by 16.69% to $20.0 million in 2021, then skyrocketed by 99.01% to $39.8 million in 2022, then increased by 6.39% to $42.4 million in 2023, then rose by 14.11% to $48.3 million in 2024.
  • Its Receivables - Net was $48.3 million in FY2024, compared to $42.4 million in FY2023 and $39.8 million in FY2022.